[HTML][HTML] AI Chatbots and Telemedicine in Cancer Care: Supporting Patients and Enhancing Communications

MS Khorsand, S Heidari, R Darbani, YEK Tosi… - Kindle, 2024 - preferpub.org
AI chatbots and telemedicine are revolutionizing cancer care by providing support to
patients and enhancing communication between them and their healthcare providers. AI …

[HTML][HTML] AI-Enhanced Virtual Clinics and Telemedicine for Cancer Treatment

H Amiri, M Ghaneiyan, P Farjami, H Mehran… - Kindle, 2024 - preferpub.org
AI-enhanced virtual clinics and telemedicine are transforming cancer treatment by improving
access to care, diagnostic precision, and personalized treatment options. For patients …

Digital Pathology–based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer

MC Markowski, Y Ren, M Tierney, TJ Royce… - European Urology …, 2024 - Elsevier
Background and objective Owing to the expansion of treatment options for metastatic
hormone-sensitive prostate cancer (mHSPC) and an appreciation of clinical subgroups with …

[PDF][PDF] Artificial intelligence-driven precision medicine in cancer treatment

M Hassane - Science, 2024 - premierscience.com
Cancer continues to be a global health challenge, with millions of new cases and deaths
each year. Recent advances in artificial intelligence (AI) are revolutionizing cancer care by …

[PDF][PDF] Innovations and Emerging Trends in Prostate Cancer Management: A Literature Review

N Ibraheem, M Abdelglil, A Wanees, AM Aosmali… - Cureus, 2024 - cureus.com
Prostate cancer (PC) is considered the second most diagnosed cancer in men worldwide. It
remains a leading cause of cancer-related death. Recently, many modalities have been …

[PDF][PDF] El futuro de la Urología ante el avance de la inteligencia artific ial: oportunidades y retos. Una visión desde la bioética

AA Medina, C de la Pinta Alonso - researchgate.net
Con el conocimiento disponible y la creciente implantación de la inteligencia artificial (IA) en
todos los ámbitos, ya no es una visión futurista, sino realista, prever que en un futuro …

The Promise and Challenges of Genomic Classifiers in Localized Prostate Cancer

SAA Naqvi, IB Riaz - Annals of Internal Medicine, 2025 - acpjournals.org
In their article, Tabriz and colleagues review studies evaluating genomic classifiers (GCs)
Oncotype DX, Genomic Prostate Score, and Prolaris to inform on risk reclassification and …

[PDF][PDF] Zahra Ovaisi

M Bayanati, F Amini, A Shafiee, Z Molaei, JT Talesh… - researchgate.net
Background Colorectal cancer (CRC) is a prevalent form of cancer, ranking as the second
most common cancer in women and the third in men. It is the fourth leading cause of cancer …

[PDF][PDF] Precision Medicine in Prostate Cancer: Integrating Genomics, AI, and Big Data for Personalized Treatment

AA Fortunate - rojournals.org
Prostate cancer (PCa) remains one of the most prevalent cancers among men worldwide,
exhibiting significant heterogeneity in its molecular profile and clinical course. Traditional …

[CITAS][C] Leveraging Artificial Intelligence to Improve Risk Stratification in Nonmetastatic Castration-Resistant Prostate Cancer

CB Nguyen, TB Dorff - JCO Precision Oncology, 2025 - ascopubs.org
Histopathology plays an essential role in cancer diagnoses and guides treatment decisions.
Prostate cancer uniquely relies on histopathology, specifically the Gleason grade …